Five-year survival in patients with endometrioid carcinoma of the ovary versus those with serous carcinoma

European Journal of Gynaecological Oncology

Volumn 19, Issue 3, 1998, Pages 225-228

  Zwart, J ^a   Geisler, J P ^a   Geisler, H E ^a  

^a ST VINCENT HOSPITAL   (United States)

Author keywords

Endometrioid; Ovarian cancer; Progesterone receptor; Serous

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL ARTICLE; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; OVARY CARCINOMA;

CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MATCHED-PAIR ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0031898044     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. thed. St. Louis, Milano, Mosby Year Book, 1993, 333.
2. American Cancer Society. Cancer facts and Figures (1994).
3. Coppleson M.: "Gynecologic Oncology: fundamental principles and clinical practice". Edinburgh, Churchill Livingstone, vol. 2, 1981, 633.
4. Björkholm E., Pettersson F., Einhorn N., Krebs I., Nilsson B. and Tjernberg B.: "Long term follow-up and prognostic factors in ovarian carcinoma: The Radiumhemmet series 1958 to 1973" Acta Radiol. Oncol., 1982, 21, 413-419.
5. Einhorn N., Nilsson B., Sjövall K.: "Factors influencing survival in carcinoma of the ovary". Cancer, 1985, 55, 2019.
6. Balvert-Locht H., Coebergh J., Hop W., Brölmann H., Crommelin M., Van Wijck D., Verhagen-Teulings M.: "Improved prognosis of ovarian cancer in the Netherlands during the period 1975-1985: A registry-based study". Gynecologic Oncology, 1991, 42, 3-8.
7. Makar A , Baekelandt M., Tropé C., Kristensen G. ́The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer". Gynecological Oncology, 1995, 56, 175.
8. Tornos C., Silva E., Khorana S , Burke T.: "High-stage endometrioid carcinoma of the ovary: Prognostic significance of pure versus mixed histology types". Am. J. Surg Pathol., 1994, 18 (7), 687
9. Schray M., Martinez A., Cox R., Ballon S.: "Radiotherapy in epithelial ovarian cancer: Analysis of prognostic factors based on long-term experience". Obstet. Gynecol., 1983, 62, 373.
10. Makar A., Kristensen G., Kaern J , Børmer O , Abeler V., Tropé C.: "Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer. New aspects and multivariate analysis". Obstet. Gynecol., 1992, 79, 1002.
11. Aure J., Høeg K., Kolstad P.: "Clinical and histologic studies of ovarian carcinoma: Longterm follow-up of 990 cases". J. Obstet. Gynecol., 1971, 37, 1-9.
12. Lund B., Williamson P.: "Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma". Obstet. Gynecol., 1990, 76, 617.
13. Roszkowski P., Wronkowski Z , Szamborski J., Romejko M : "Evaluation of selected prognostic factors in ovarian cancer". Eur. J. Gynaecol. Oncol., 1993, 14, 140.
14. Makar A., Kristensen G., Børmer O , Tropé C.: "CA 125 measured before second-look laparotomy is an independent factor for survival in patients with epithelial ovarian cancer". Gynecol. Oncol., 1992, 45, 323.
15. International Federation of Gynecology and Obstetrics: "Classification and staging of malignant tumors in the female pelvis". J. Int. Fed. Gynecol , 1965, 3, 204.
16. Griffiths C.: "Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma". Natl. Cancer. Inst. Monogr., 1975, 42, 101.
17. Griffiths C., Parker L., Fuller A. Jr.: "A role of cytoreductive surgical treatment in the management of advanced ovarian cancer". Cancer Treat. Rep., 1979, 63, 235.
18. Tobias J., Griffiths C.: "Management of ovarian carcinoma. current concepts and future prospects". NEJM, 1976, 294, 818.
19. Geisler J. P., Wiemann M. C., Geisler H. E.: "Optimal cytoreductive surgery in the elderly woman with stage IIIc serous cystadenocarcinoma of the ovary". J. Pelvic Surg., 1995, 1, 32.
20. Peter A., Heintz M.: "Surgery in ovarian cancer: the concept of cytoreductive surgery". Cur. Opin Obstet. Gynecol., 1996, 8, 8.
21. Cuesta R., Eichhorn J., Rice L., Fuller A., Nikrui N., Goff B.: "Histologic transformation of benign endometriosis to early epithelial ovarian cancer". Gynecol. Oncol., 1996, 60, 238.
22. McMeekin D., Burger R., Manetta A., DiSaia P., Berman M.: "Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis". Gynecol. Oncol , 1995, 59, 81.
23. Bardi M., Arnoldi E., Pizzocchero G , Pezzica E., Mattioni D., Perotti M.: "Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with Tamoxifen adjuvant therapy for breast cancer". Eur. J. Gynaecol. Oncol., 1994, 15, 393.
24. Cohen I., Altaras M., Lew S., Tepper R., Beyth Y., BenBaruch G.: "Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patients during tamoxifen therapy: A case report and review of the literature". Gynecol. Oncol., 1994, 55, 447.
25. Quinn M., Pearce P., Rome R., Funder J., Fortune D., Pepperell R.: "Cytoplasmic steroid receptors in ovarian tumors". Br. J. Obstet. Gynaecol., 1982, 89, 754.
26. Creasman W., Sasso R., Weed J. Jr., McCarty K. Jr.: "Histological and clinical correlation of cytoplasmic estrogen and progesterone binding". Gynecol. Oncol., 1981, 12, 319.
27. Geisler J. P., Wiemann M. C., Miller G. A., Zhou Z., Geisler H. E.: "Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduce stage IIIC serous cystadenocarcinoma of the ovary". Gynecol. Oncol., 1996, 60, 424.